Novartis Aktie
112,10
EUR
-1,15
EUR
-1,02
%
104,08
CHF
-0,44
CHF
-0,42
%
Werbung
Novartis Aktie Analyse
| 20.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 15.01.21 | Novartis buy | Deutsche Bank AG | |
| 14.01.21 | Novartis buy | UBS AG | |
| 13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.01.21 | Novartis overweight | Morgan Stanley | |
| 04.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.12.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 11.12.20 | Novartis buy | Jefferies & Company Inc. | |
| 10.12.20 | Novartis buy | Jefferies & Company Inc. | |
| 27.11.20 | Novartis Underweight | Barclays Capital | |
| 25.11.20 | Novartis buy | UBS AG | |
| 25.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.11.20 | Novartis buy | UBS AG | |
| 28.10.20 | Novartis Neutral | Credit Suisse Group | |
| 27.10.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.20 | Novartis Underweight | Barclays Capital | |
| 27.10.20 | Novartis buy | Jefferies & Company Inc. | |
| 21.10.20 | Novartis overweight | Morgan Stanley | |
| 14.10.20 | Novartis buy | UBS AG | |
| 13.10.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 30.09.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 29.09.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.09.20 | Novartis Underweight | Barclays Capital | |
| 23.09.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.09.20 | Novartis buy | UBS AG | |
| 01.09.20 | Novartis overweight | Morgan Stanley | |
| 26.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.08.20 | Novartis Neutral | UBS AG | |
| 21.08.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 18.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.07.20 | Novartis neutral | Morgan Stanley | |
| 22.07.20 | Novartis Hold | HSBC | |
| 22.07.20 | Novartis Neutral | Credit Suisse Group | |
| 22.07.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.07.20 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.20 | Novartis Hold | Kepler Cheuvreux | |
| 21.07.20 | Novartis Neutral | UBS AG | |
| 21.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis buy | Jefferies & Company Inc. | |
| 21.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.06.20 | Novartis Neutral | UBS AG | |
Werbung
Werbung